Wasatch Advisors LP 13D and 13G filings for Esperion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-14 5:08 pm Sale | 2026-06-30 | 13G | ESPERION THERAPEUTICS INC ESPR | Wasatch Advisors LP | 1,930,185 0.700% | -13,838,712 (-87.76%) | Filing |
| 2026-04-22 3:44 pm Purchase | 2026-03-31 | 13G | ESPERION THERAPEUTICS INC ESPR | Wasatch Advisors LP | 15,768,897 6.100% | 8,707,040 (+123.30%) | Filing |
| 2025-11-12 3:32 pm Sale | 2025-09-30 | 13G | ESPERION THERAPEUTICS INC ESPR | Wasatch Advisors LP | 7,061,857 3.500% | -3,869,400 (-35.40%) | Filing |
| 2025-04-07 2:15 pm Sale | 2025-03-31 | 13G | ESPERION THERAPEUTICS INC ESPR | Wasatch Advisors LP | 10,931,257 5.500% | -4,232,629 (-27.91%) | Filing |
| 2024-02-09 4:14 pm Purchase | 2024-02-09 | 13G | ESPERION THERAPEUTICS INC ESPR | Wasatch Advisors LP | 15,163,886 12.600% | 5,362,725 (+54.72%) | Filing |
| 2023-02-10 1:46 pm Purchase | 2023-02-10 | 13G | ESPERION THERAPEUTICS INC ESPR | Wasatch Advisors LP | 9,801,161 12.800% | 462,115 (+4.95%) | Filing |
| 2022-02-11 2:54 pm Purchase | 2022-02-11 | 13G | ESPERION THERAPEUTICS INC ESPR | Wasatch Advisors LP | 9,339,046 14.400% | 5,341,036 (+133.59%) | Filing |